Results 251 to 260 of about 173,420 (380)

Contraceptive use among adolescent girls and young women ages 15-24 in seven high HIV prevalence countries. [PDF]

open access: yesFront Reprod Health
Greenleaf AR   +9 more
europepmc   +1 more source

Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Children with primary immunodeficiency (PID) and secondary antibody deficiency (SAD) often require immunoglobulin replacement therapy due to low plasma immunoglobulin G (IgG) levels and recurrent infections. Existing pharmacokinetic models for immunoglobulin in PID patients predominantly focus on adults, with limited attention to ...
Iek Leng Cheng   +4 more
wiley   +1 more source

Correlates of intention to use condoms among Sub-Saharan African youth: The applicability of the theory of planned behaviour

open access: yesScandinavian Journal of Public Health, 2009
H. Schaalma   +7 more
semanticscholar   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Behavioural interventions promoting condom use among female sex workers in sub-Saharan Africa: a systematic review

open access: hybrid, 2017
Uchenna Okafor   +4 more
openalex   +1 more source

Overcoming denial and increasing the intention to use condoms through the induction of hypocrisy.

open access: yesAmerican Journal of Public Health, 1991
E. Aronson, Carrie B. Fried, J. Stone
semanticscholar   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy